A full listing of our work can be found at the two following sites (Research Gate and PubMed) and below.

ResearchGate: https://www.researchgate.net/profile/Stephanie_Watts

PubMed: https://www.ncbi.nlm.nih.gov/sites/myncbi/stephanie.watts.1/bibliography/41165307/public/?sort=date&direction=descending


1991

Watts, S. W. and Cohen, M. L.: Heterogeneous response of rat genitourinary tissues to substance P, bradykinin, bombesin, and calcitonin-gene related peptide.  Peptides, 12: 1057-1062, 1991.

 

1992

Watts, S. W. and Cohen, M. L.: Characterization of the contractile serotonergic receptor in guinea pig trachea with agonists and antagonists.  J. Pharmacol. Exp. Ther., 260: 1101-1106, 1992.

 

1993

Watts, S. W. and Cohen, M. L.: Further evidence that the guinea pig tracheal contractile serotonergic receptor is a 5-HT2 receptor: use of 5-methyltryptamine and dipropyl-5-carboxamidotryptamine, J. Pharmacol. Exp. Ther., 264: 271-275, 1993.

Watts, S. W. and Cohen, M. L. : Time-dependent improvement of guinea pig tracheal contractility: modification by cyclooxygenase inhibitors, J. Pharmacol. Exp. Ther., 266: 950-957, 1993.

Watts, S. W., Traub, O., Myers, J.-H., Lamb, F. S. and Webb, R. C.: Effect of ramipril on a-receptor-mediated oscillatory contractions in tail artery of hypertensive rats, Eur. J. Pharmacol., 242: 254-253, 1993.

 

1994

Watts, S. W., Stengel, P. W. and S. A. Silbaugh.  Serotonin receptors in respiratory smooth muscle and respiratory diseases, Drug News & Perspectives, vol. 7 (1), 19-25, 1994.

Watts, S. W., Baez, M., Mooney, P. Q., Johnson, B. G., Schoepp, D. D. and Cohen, M. L.: Disruption of potential alpha-helix in the G loop of the guinea pig 5-hydroxytryptamine2 (5-HT2) receptor does not prevent receptor-coupling to phosphoinositide hydrolysis, J. Neurochem., 62: 934-943, 1994.

Watts, S. W. and Webb, R. C.: Mechanism of ergonovine-induced contraction in deoxycorticosterone acetate-salt hypertensive rats, J. Pharmacol. Exp. Ther., 269: 617-625, 1994.

Watts, S. W., Gackenheimer, S., Gehlert, D. G. and Cohen, M. L.:  Autoradiographic localization of the 5-HT2 receptor in rat and guinea pig brain, Neurochem. Internat., 24: 565-574, 1994.

Watts, S. W., Schenck, K. W. and Cohen, M. L.:  Selective desensitization of the 5-HT2 receptor mediated contraction in guinea pig trachea,Can. J. Physiol. Pharmacol., 72: 463-470, 1994.

Watts, S. W., Traub, O. and Webb, R. C.: Effects of ramipril on contractile oscillations in arteries from genetically hypertensive rats,Clin. Exp. Hypertension, 16 (6): 881-898, 1994.

Watts, S. W., Finta, K., Lloyd, M. C., Storm, D. S. and Webb, R. C.: Enhanced vascular responsiveness to BayK 8644 in mineralocorticoid- and N-nitro arginine-induced hypertension, Blood Pressure, 3: 340-348, 1994.

Watts, S. W., Johnson, B. G., Schoeppe, D. and Cohen, M. L.:  5-HT2A receptor signal transduction in guinea pig trachea:  attempts to optimize detection of PI hydrolysis and role of extracellular calcium, J. Pharmacol. Exp. Ther., 271: 832-844, 1994.

Watts, S. W., Tsai, M.-Ling, Loch-Caruso, R. and Webb, R. C.: Gap junctional communication and vascular smooth muscle reactivity: Use of tetraethylammonium chloride,J. Vasc. Res., 31: 307-313, 1994.

 

1995

Killam, A. L., Watts, S. W. and Cohen, M. L.: Role of a1 and 5-HT2 receptors in serotonin-induced contraction of rat prostate: autoradiographical and functional studies,Eur. J. Pharmacol., 273: 7-14, 1995.

Watts, S. W., Chai, S. and Webb, R. C.: Lead acetate-induced contraction in rabbit mesenteric artery: Interaction with calcium and protein kinase C, Toxicology, 99:55-65, 1995.

Watts, S. W., Gilbert, L. and Webb, R. C.:  5-HT2B receptor mediates contraction to 5-HT in the mesenteric artery of DOCA-salt hypertensive rats, Hypertension, 26: 1056-1059, 1995.

Tsai, M.-L., Watts, S. W., Loch-Caruso, R. and Webb, R. C.:  Role of gap junctional communication in enhanced vascular reactivity in arteries from hypertensive rats, J. Hypertension, 13:1123-1133, 1995.

 

1996

Cox, D. A., Watts, S. W. and Cohen, M. L.: Neomycin selectively inhibits 5-hydroxytryptamine-induced contraction in the guinea pig trachea, J. Pharmacol. Exp. Ther., 277:954-959, 1996.

Watts, S. W., Baez, M. and Webb, R. C.: The 5-HT2B receptor and 5-HT receptor signal transduction in vascular smooth muscle from DOCA-salt hypertensive rats, J. Pharmacol. Exp. Ther., 272:1103-1113, 1996.

Watts, S. W., Yeum, C. H., Campbell, G. and Webb, R. C.: Serotonin stimulates protein tyrosyl-phosphorylation and vascular contraction via tyrosine kinase, J. Vasc. Res., 33:288-298, 1996.

Goud, C., Watts, S. W. and Webb, R. C.:  Photorelaxation is not attenuated by inhibition of the nitric oxide cGMP pathway, J. Vasc. Res., 33: 299-307, 1996.

Kanagy, N. L., Sarkar, R. J., Watts, S. W. and Webb, R. C.: Non-cGMP, paracrine effects of nitric oxide in the vasculature, in Endocrinology of the Vasculature, ed. by J. R. Sowers and M. Walsh, Humana Press, Totawa, pp.37-47, 1996.

Javid, P. J., Watts, S. W. and Webb, R. C.: Inhibition of nitric oxide-induced vasodilation by gap junction inhibitors: a potential role for cGMP-independent nitric oxide pathway, J. Vasc. Res., 33: 395-404, 1996

Watts, S. W. and Webb, R. C.: Vascular gap junctional communication is increased in mineralocorticoid-salt hypertension, Hypertension, 28:888-893, 1996.

Watts, S. W.:  Serotonin activates the mitogen-activated protein kinase pathway in vascular smooth •muscle: Use of the mitogen activated protein kinase kinase inhibitor PD098059, J. Pharmacol. Exp. Ther., 279:1541-1550, 1996.

 

1997

Watts, S. W. and Webb, R. C.: Vascular gap junctional communication and heptanol-response, Hypertension, 30:306, 1997.

Tithof, P. K., Watts, S. W. and Ganey, P.: Protein tyrosine kinases are involved in the production of superoxide anion by neutrophils exposed to the mixture of polychlorinated biphenyls Aroclor 1242, Biochemical Pharmacology, 53: 1833-1842, 1997.

Grekin, R., Dumont, C., Vollmer, A., Watts, S. W. and Webb, R. C.: Mechanisms in the pressor effect of hepatic portal venous fatty acid infusion, American Journal of Physiology, 273: R342-R330, 1997.

Watts, S. W.: The 5-HT2B receptor antagonist LY272015 inhibits 5-HT-induced contraction in the aorta of mineralocorticoid-salt hypertensive rats, J. Serotonin Res., 4(3):197-206, 1997.

 

1998

Monroe, K. and Watts, S. W.: The vascular reactivity of melatonin, General Pharmacology, 30:931-935, 1998.

Florian, J. A. and Watts, S. W.:  Integration of MEK activation in vascular 5-HT2A receptor signal transduction, J. Pharmacol. Exp. Ther., 284:346-355, 1998.

Watts, S. W.: The development of enhanced arterial serotonergic hyperresponsiveness in mineralocorticoid hypertension, J. Hypertension, 16:811-822, 1998.

Watts, S. W.: Activation of the mitogen activated protein kinase pathway via the 5-HT2A receptor, Ann New York Acad. Sci., 861:162-168, 1998.

Watts, S. W., Florian, J. A. and Monroe, K. M.: Dissociation of angiotensin II-stimulated activation of mitogen activated protein kinase kinase from vascular contraction, J. Pharmacol. Exp. Ther., 286:1431-1438, 1998.

 

1999

Florian, J. A. and Watts, S. W.: Epidermal Growth Factor: a potent vasoconstrictor in experimental hypertension, Am. J. Physiol., 276:H976-H983, 1999.

Watts, S. W. and Fink, G. D.:  The 5-hydroxytryptamine2B receptor antagonist LY272015 is antihypertensive in severely hypertensive deoxycorticosterone acetate salt rats, Am. J. Physiol., 276:H944-H952, 1999.

Watts, S. W., Florian, J. A. and Banes, A.: Mechanisms of 5-HT2A receptor activation of the mitogen activated protein kinase pathway in vascular smooth muscle, J. Pharmacol. Exp. Ther., 291:1179-1187, 1999.

Watts, S. W. and Harris, B. J.: Is functional upregulation of the 5-HT2B receptor in deoxycorticosterone acetate salt-treated rats blood pressure-dependent?, Gen. Pharmacol, The Vasc. System, 33(6): 439-447, 1999.

 

2000

Watts, S. W., Fink, G. D., Silver, P. and Cushing, D.J.: Interaction of the beta receptor adrenergic antagonist bucindolol with serotonergic receptors, J. Cardiovasc. Pharmacol. 35(1):29-36, 2000.

Watts, S. W.: 5-HT-induced potentiation of ET-1 and NE-induced Contraction is MAPK pathway-dependent, Hypertension, 35:244-248, 2000.

Russell, A. and Watts, S. W.: Vascular reactivity of the isolated thoracic aorta of the C57BL/6J mouse. J. Pharmacol. Exp. Ther., 294:598-604, 2000.

Melis, A., Watts, S. W., Florian, J., Klarr, S. and Webb, R. C.: Insulin-like growth factor inhibits vascular contraction to serotonin: involvement of tyrosine phosphatase, Gen. Pharmacol., The Vasc. System, 34:137-145, 2000.

 

2001

Ballew, JR, Watts, S.W. and Fink, G.D.: Effects of salt intake and angiotensin II on vascular reactivity to endothelin-1, J. Pharmacol. Exp. Ther., 296:345-350, 2001.

McKune, C. and Watts, S. W.: Characterization of the serotonin receptor mediating contraction in the mouse thoracic aorta, J. Pharmacol. Exp. Ther.,297: 88-95, 2001.

Xu, H., Fink, G. D., Chen, A., Watts, S. W. and Galligan, J. J.: Nitric oxide-independent effects of tempol on sympathetic nerve activity and blood pressure in normotensive rats, Am. J. Physiol. 281:H975-H980, 2001.

Atkins, K. B., Johns, D., Watts, S.W., Webb, R. C. and Brosius FC III.  Decreased vascular glucose transporter expression and glucose uptake in DOCA-salt hypertension.  J. Hypertens. 19:1581-1587, 2001.

Florian, J. A., Dorrance, A., Webb, R. C. and Watts, S. W.: Mineralocorticoids upregulate arterial contraction to epidermal growth factor, Am. J. Physiol. Reg Int & Comp. 281:R878-R886, 2001.

Banes, A. K. and Watts, S. W.: Enhanced contraction to 5-HT is not due to unmasking of the 5-HT1B receptors in the mesenteric artery of the DOCA-salt rat, Hypertension, 38:891-895, 2001.

Banes, A. K. L., Loberg, R. D., Brosius, F. C. and Watts, S. W.: Inability of serotonin to activate the c-Jun-N-terminal kinase and p38 kinase pathways in rat aortic vascular smooth muscle cells, BMC Pharmacology 2001, 1:8. 

Watts, S. W., Yang, P., Banes, A. K. and Baez, M.: Activation of Erk MAPK proteins by vascular serotonin receptors, J. Cardiovasc. Pharmacol., 38:539-551, 2001. 

Northcott, C., Florian, J. A., Dorrance, A. and Watts, S. W.: Arterial epidermal growth factor receptor expression in DOCA-salt hypertension,  Hypertension, 38:1337-13341, 2001.

 

2002

Banes, A. B. and Watts, S. W.: Upregulation of arterial serotonin1B and 2B receptors in DOCA-salt hypertension, Hypertension, 39:394-398, 2002.

Watts, S. W.: Serotonin-induced contraction in mesenteric resistance arteries: signalling and changes in hypertension, Hypertension, 39:825-829, 2002.

Johnson, R. J, Fink, G. D., Watts, S. W. and Galligan, J.J.: Endothelin receptor function in mesenteric veins from deoxycorticosterone acetate salt hypertensive rats, J. Hypertension, 20(4): 665-676, 2002.

Watts, S. W., Fink, G. D., Northcott, C. A. and Galligan, J. J.: Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension; studies with receptor agonists, Br. J. Pharmacol. 137:69-79, 2002.

Northcott, C. A., Poy, M. N., Najjar, S. M. and Watts, S. W.: PI3-kinase mediates enhanced spontaneous and agonist-induced contraction in aorta of DOCA-salt hypertensive rats, Circ. Res, 91:360-369, 2002; Editorial on page 273-275. 

Russell, A., Banes, A., Berlin, H., Fink, G.D. and Watts, S. W.: 5-Hydroxytryptamine2B receptor function is enhanced in the Nw-nitro-L-arginine hypertensive rat, J. Pharmacol. Exp. Ther., 303:179-187, 2002.

 

2003

Li, L., Fink, G. D., Watts, S. W., Northcott, C. A., Galligan, J. J., Pagano, P. J. and Chen, A. F.: ET-1 increases vascular superoxide via ETA-NADPH oxidase pathway in low renin hypertension,  Circulation, 107:1053-1058, 2003.

Loberg, R., Northcott, C., Watts, S. W. and Brosius, F.: PI-3-Kinase –induced hyperreactivity in DOCA-salt hypertension is independent of GSK-3 activity, Hypertension, 41:898-902, 2003.

Li, L., Watts, S. W., Banes, A. K., Galligan, J. J., Fink, G. D. and Chen, A. F.: Superoxide augments endothelin-1 induced venoconstriction in mineralocorticoid hypertension, Hypertension, 42:316-321 2003. 

Banes, A. K.L. and Watts, S. W.: Arterial expression of 5-HT2B and 5-HT1B receptors during development of DOCA-salt hypertension, BMC Pharmacology,3:12 2003.

 

2004

Northcott, C. A. and Watts, S. W.: Low Mg2+ enhances arterial spontaneous tone via PI3K in DOCA-salt Hypertension, Hypertension, 43:125-130, 2004.

Thakali, K., Fink, G. D. and Watts, S. W.: Arteries and veins desensitize differently to endothelin-1, J. Cardiovasc. Pharmacol., 43:387-393, 2004.

Watts, S. W. and Thompson, J. M.: Characterization of a 5-HT2B-like receptor in the renal artery of the normotensive rat, J. Pharmacol. Exp. Ther., 309: 165-172, 2004.

Northcott, C. A., Hayflick, J. S. and Watts, S. W.: PI3-Kinase upregulation and involvement in spontaneous tone in arteries from DOCA-salt rats: is p110delta the culprit, Hypertension, 43:885-890,  2004.

Northcott, C. A. and Watts, S. W.:  Letter to the Editor, Response to Magnesium in Hypertension.    Hypertension, 43:e29,  2004. 

Ni, W., Li, M., Thakali, K., Fink, G. D. and Watts, S. W.: The fenfluramine metabolite (+)-norfenfluramine is vasoactive,  J. Pharmacol. Exp. Ther., 309:845-852, 2004.

Dai, X., Galligan, J. J., Watts, S. W., Fink, G. D. and Kreulen, D. L.: Increased O2- production and upregulation of ETB receptors by sympathetic neurons in DOCA-salt hypertensive rats, Hypertension, 43:1048-1054, 2004.

Wehrwein, E. A., Northcott, C. A., Lobert, R. D. and Watts, S. W.: Rho/Rho kinase and PI3-kinase are parallel pathways in the development of spontaneous arterial tone in deoxycorticosterone acetate-salt hypertension, J. Pharmacol. Exp. Ther., 309:1036 -1042, 2004. 

Slovut, D. P., Mehta, S., Dorrance, A. M., Brosius, F. C, Watts, S. W. and Webb, R. C.: Heightened vasoreactivity after sympathetic denervation correlates with increased connexin43 expression, Cardiovasc Research, 62: 388-396, 2004.

Ni, W., Thompson, J., Northcott, C., Lookingland, K. and Watts, S. W.: The serotonin transporter is present and functional in peripheral arterial smooth muscle, J. Cardiovasc. Pharmacol., 43:770-781, 2004.

Watts, S. W.: C3 or not C3: that is the question.  Hypertension, 44:25-26, 2004. 

 

2005

Wang, H., Galligan, J. J., Chen, A. L., Watts, S. W. and Fink, G. D.: Endothelin in the splanchnic vascular bed of DOCA-salt hypertensive rats, Am. J. Physiol Heart Circ, 288:H72-H736, 2005.

Atkins, K. B., Northcott, C. A., Watts, S. W. and Brosius, F. C.: Effect of PPARg ligands on vascular smooth muscle marker expression in hypertensive and normal arteries, Am J Physiol. Heart Circ, 288:H235-H243, 2005.

Toews, M.L., Watts, S. W. and Beckman, B. S.: Preserving and promoting our discipline: pharmacology students speak out.  Mol. Interven. 5:4-7, 2005.

Watts, S. W.: 5-HT in Systemic Hypertension: friend, foe or fantasy? Clinical Sci., 108:399-412, 2005.

Thakali, K., Demel, S. L., Fink, G. D. and Watts, S. W.: Endothelin-1 (ET-1)-induced contraction in veins is independent of hydrogen peroxide (H2O2), Am. J. Physiology Heart Circ, 289:H1115-1122, 2005.

Ni, W., Wilhelm, C. S., Bader, M., Murphy, D. L., Lookingland, K. and Stephanie W. Watts: (+)-Norfenfluramine-induced arterial contraction is not dependent on endogenous 5-HT or 5-HTT, J. Pharmacol. Exp. Ther., 314L953-960, 2005. 

Northcott, C. A. and Watts, S. W.: Upregulated function of phosphoinositide-3-kinase (PI-3-K) in genetically hypertensive rats: a moderator of arterial hypercontractility, Clin. Exper. Physiol. Pharmacol., 32:851-858, 2005.

Xu, H., Bian, X., Watts, S. W., and Hlavacova, A.: Activation of vascular BK channel by tempol in DOCA-salt hypertensive rats, Hypertension, 46:1154-1162, 2005.

Watts, S. W.: Vasoconstriction caused by the ATP synthase subunit coupling factor 6: a new function for an historical enzyme, Hypertension, 46:1100-1102, 2005.

 

2006

Thakali, K., Davenport, L., Fink, G. D. and Watts, S. W.: Pleiotropic effects of hydrogen peroxide in arteries and veins from normotensive and deoxycorticosterone acetate-salt hypertensive rats, Hypertension, 47:482-487, 2006.

Ni, W. and Watts, S. W.: 5-HT in the cardiovascular system: focus on the serotonin transporter (SERT), Clin. Exp. Pharmacol. Physiol, 33:575-583, 2006.

Thakali K. M., Lau, Y., Fink, G. D., Galligan, J. J., Chen, A. F. and Watts, S. W.: Mechanisms of hypertension induced by nitric oxide (NO) deficiency: focus on venous function, J. Cardiovasc Pharmacol., 47:742-740, 2006. 

Ni, W., Lookingland, K. and Watts, S. W.: Arterial 5-HT transporter function is impaired in DOCA-salt hypertensive but not spontaneously hypertensive rats, Hypertension, 48:134-140, 2006.  

Ogden, K., Thompson, J. M., Hickner, Z., Huang, T., Tang D. D. and Watts, S. W.:  A new signaling paradigm for serotonin: Use of Crk-Associated substrate in arterial contraction, Am. J. Physiology Heart Circ Phys, 291:H2857-H2863, 2006.

Ni, W.,Lookingland, L. and Watts, S. W.:  Response to “Blood pressure in mutant rats lacking the 5-hydroxytryptamine (5-HT) transporter, Hypertension, ePrint, Oct 2006.

 

2007

Szasz, T., Thakali, K., Fink, G. D. and Watts, S. W.: A comparison of arteries and veins in oxidative stress:  producers, destroyers, function and disease, Soc. Exp. Biol. Med, 232:27-37, 2007.

Thakali, K., Davenport, L., Fink, G. D. and Watts, S. W.: Cyclooxygenase, p38 MAPK, Erk MAPK, Rho Kinase and Src mediate hydrogen peroxide induced contraction of rat thoracic aorta and vena cava, J. Pharmacol. Exp. Ther., 320:236-243, 2007. 

Rondelli, C. , Kayal, A., Szasz, T., Thakali, K., Watson, R. E., Rovner, A. S., Eddinger, T. J., Fink G. D. and Watts, S. W.  Preferential myosin heavy chain isoform B expression may contribute to the faster velocity of contraction in veins vs arteries.  J Vasc Res, 44:264-272, 2007. 

Watts, S. W., Rondelli, C., Thakali, K., Pervaiz, M., Watson, R. and Fink, G. D.:  Morphologic and Biochemical characterization of remodeling in aorta and vena cava of DOCA-salt hypertensive rats, Am. J. Physiology Heart Circ, 292:H2438-2448, 2007. 

Ni, W, Fink, G. D. and Watts, S. W.: The 5-HT2A receptor is involved in (+) norfenfluramine-induced arterial conraction and blood pressure increase in DOCA-salt hypertension, J. Pharmacol. Exp. Ther. 321:485-491, 2007.

Fink, G. D., Li, M., Lau, Y., Osborne, J. and Watts, S. W.: Chronic activation of endothelin ETB receptors: A new model of experimental hypertension, Hypertension, 50:512-518, 2007. 

Linder, A. E., Ni, W., Diaz, J. L., Szasz, T., Burnett, R. and Watts, S. W.: 5-HT in veins: not all in vain, invited Perspectives in Pharmacology J. Pharmacol. Exp. Ther., 323:415-421, 2007. 

Linder, A.E., Thakali, K., Thompson, J., Watts, S. W., Webb, R. C. and Leite, R.:  Methyl-b-cyclodextrin prevents angiotensin II-induced tachyphylactic contractile responses in rat aorta, J Pharmacol Exp Ther., 323:78-84, 2007. 

Ogden, K. K., Falck, J. R. and Watts, S. W.: The cytochrome P450 inhibitor ketoconazole potentiates 5-hydroxytryptamine-induced contraction in rat aorta, J. Pharmacol. Exp. Ther., 323:606-613, 2007.

Watts, S. W., Thakali, K., Rondelli, C and Fink, G. D.: Processing of big ET-1 into vasoactive peptides: comparison of arteries and veins, Vascular Pharmacology, 47:302-312, 2007. 

 

2008

Huang J, Lin SC, Nadershahi A, Watts SW, Sarkar R. Role of redox signaling and poly (adenosine diphosphate-ribose) polymerase activation in vascular smooth muscle cell growth inhibition by nitric oxide and peroxynitrite., J Vasc Surg. 47(3):599-607, 2008.

Linder, A. E., Diaz, J., Ni, W., Szasz, T., Burnett, R. and Watts, S. W.: Vascular reactivity, 5-HT uptake and blood pressure in the serotonin transporter knockout rat, Am J Physiol Heart Circ Physiol, 294:H1745-H1752, 2008. 

Thakali, K., Galligan, J. J., Fink, G. D., Gariepy, C. E. and Watts, S. W.: Pharmacological endothelin receptor interaction occurs in veins but not arteries, Vascular Pharmacology, 49:6-13, 2008. 

Ni, W, Geddes, T. J., Priestley, J. R. C., Szasz, T., Kuhn, D. M. and Watts, S. W.: The existence of a local serotonergic system in peripheral arteries, Br J Pharmacol, 154:663-674, 2008.

Diaz, J., Ni, W., King, A., Fink, G. D. and Watts, S. W.: 5-hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats.  J Pharmacol Exp Ther, 325:1031-1038, 2008. 

Linder, A. E., Ni, W., Szasz, T., Burnett, R., Diaz, J., Geddes, T. J., Kuhn, D. M. and Watts, S.W.: A serotonergic system in veins: serotonin-transporter independent uptake, J. Pharmacol. Exp. Ther., 325:714-722, 2008.

Ni, W., Zhou, H., Diaz, J., Murphy, D. L., Haywood, J. R.  and Watts, S. W.: Lack of the serotonin transporter does not prevent mineralocorticoid hypertension in rat and mouse, Eur. J Pharmacol, 589:225-227, 2008. 

Szasz, T., Thompson, J. M. and Watts, S. W.: A comparison of reactive oxygen species metabolism in aorta and vena cava of the normal rat: focus on xanthine oxidase, Am J Physiol Heart Circ Physiol 295:H1341-H1350, 2008. 

Watts, S. W.: The beginning of a fantastic, unanswered question: is 5-HT involved in systemic hypertension, Am J Physiol Heart Circ Physiology, 295:H915-H916, 2008. 

Li, M., Dai, X., Watts, S.W., Kreulen, D. and Fink, G. D.: Increased superoxide levels in ganglia and sympathoexcitation are involved in S6c-induced hypertension.  Am J Physiol Reg Integr Comp Physiol, 295:R1546-R1554, 2008. 

 

2009

Watts, S. W.: The love of a lifetime: 5-HT in the cardiovascular system, Am J Physiol Reg Integr Comp Physiol, 296:R252-R256, 2009. PMID 18753260

Szasz, T., Eddy, S., Paulauskis, J., Burnett, R., Ellekilde, M., Iovanna, J. L. and Watts, S. W.: Arterial vs venous expression of genes: differences in inflammatory genes, J Vasc Res, 46:551-560, 2009.

Linder, A. E., Beggs, K., Burnett, R. and Watts, S. W.: Body distribution of infused serotonin in rats, Clin. Exp Pharmacol. Physiol, 36:599-601, 2009. 

Tykocki, N.R., Gariepy. C.E. and Watts, S. W.: ETB receptors in arteries and veins: multiple actions in veins, J. Pharmacol. Exp. Ther., 329:875-881, 2009. 

Watts, S. W., Priestley J.R. C. and Thompson, J. M.: Serotonylation of vascular protein important to contraction, PLoS One, May 25, e5682, 2009. 

 

2010

Watts SW: Endothelin receptors:  what do we know and what do we need to know?  Am J Physiol Regul Integr Comp Physiol, 298:R254-R260, 2010. 

Seymour E. M., Watts, S. W.: Whole grape intake impacts cardiac PPAR and NFkB activity, fibrosis and cytokine expression in rats with diastolic heart failure, Hypertension, 55:1179-1185, 2010. 

Szasz, T. and Watts, S. W.: Uric acid does not impact endothelial function of aorta from normotensive and DOCA-salt hypertensive rats, J. Pharmacol. Exp. Ther., 333: 758-763, 2010.

Linder, A. E., Gaskell, G. L., Szasz, T., Thompson, J. M. and Watts, S. W.: Serotonin receptors in the rat jugular vein: presence and involvement in contraction, J. Pharmacol. Exp. Ther., 334:116-123, 2010.  

Tykocki, N. and Watts, S. W.: Calcium and ET, Clin Sci, 119:361-372, 2010.

Szasz, T, Linder AE, Davis RP, Burnett, R., Fink, G. D. and Watts, S. W.: Allopurinol does not decrease blood pressure or prevent the development of hypertension in the DOCA-salt model, J Pharmacol. Exp. Ther, 56:627-634, 2010. 

Johnson, K. B., Thompson, J. M., and Watts, S. W.: Modification of proteins by norepinephrine is important for vascular contraction, Frontiers in Vascular Physiology, Front. Physio. 1:131. doi: 10.3389/fphys.2010.00131 2010

Northcott, C., Watts, S. W., Chen, Y., Morris, M., Chen, A. F., and Haywood, J. R.: Small hairpin RNA adenoviral inhibition of AT1A receptors in the paraventricular nucleus inhibits acute increases in mean arterial blood pressure in the rat. Am J Physiol Regul Integr Comp Physiol. Nov;299(5):R1202-1211, 2010.

 

2011

Invited Review: Watts SW and Davis P: 5-Hydroxtryptamine Receptors in Systemic Hypertension: an arterial focus, Cardiovascular Therapeutics, 29:54-67, 2011. 

Ren W, Watts, S. W., Fanburg, B. L.: The serotonin transporter interacts with the PDGF (beta) receptor in PDGF-BB induced signaling and mitogenesis in pulmonary artery smooth muscle cells.  Am J Physiol. Lung Cell Mol Physiol, 300:L486-497, 2011. 

Davis, R., Linder A. E. and Watts, S W: Lack of the serotonin transporter (SERT) reduces the ability of 5-hydroxytryptamine to lower blood pressure, Naunyn Schmied. Arch. Pharmacol, 383:543-546, 2011

Linder, A, Davis, R., Burnett, R. and Watts, S. W.: The serotonin transporter mediates vascular uptake of and reactivity to serotonin in vessels from female rats, Clin. Exper. Pharmacol. Physiol., 38:314-322, 2011. 

Harrison, B., Watts, S.W., Barrett, J. E., Coupet, J., Mazandarani, H., Nawoschik, S., Pangalos, M. N., Ramamoorthy, S., Schechter, L., Smith, D. L., Stack, G., Zhang, J., Zhange, G., Rosenzweig-Lipson, S. and Dunlop, J.: Characterization of Vabicaserin (SCA-136), a functionally selective 5-HT2C receptor agonist, J. Pharmacol. Exp. Ther., 337:673-680, 2011. 

Bush, C. J., Szasz, T., Johnson, K. B., Tykocki, N. R., Surewicz, W. K., Watson, R. E. and Watts, S. W.: Prion protein is expressed in the vascular system, but recombinant human PrP does not protect vascular smooth muscle cells from oxidative stress, Reinvention 4(2), October 2011. 

Watts, S. W., Shaw, S., Burnett, R. and Dorrance, A. M.: Indoleamine 2,3-diooxygenase in perioaortic at: mechanisms of inhibition of contraction, Am. J. Physiol. Heart Circ. Physiol, 301:H1236-1247, 2011. 

Tan T, Watts, SW and Davis RP: Drug delivery: enabling technology for drug discovery and development.  IPRECIO micro infusion pump: programmable, refillable, and implantable.  Front Pharmacol 2:44, Jul 29 2011. 

 

2012

Invited Review: Watts, S. W., Morrison S. M and Barman SM:  Serotonin and Blood Pressure Regulation, Pharmacol. Rev., 64:359-388, 2012. 

Johnson K, Peterson-Jones H, Thompson, J. M., Hitomi, K., Itoh, M., Bakker ENTP, Johnson G. V. W., Colak G. and Watts, S. W.: Vena cava and aortic smooth muscle cells expression TG1 and TG4 in addition to TG2, Am. J. Physiol. Heart. Circ. Physiol., 302;H1355-1366, 2012. 

Darios E, Seitz B and Watts, S. W.: Smooth muscle pharmacology in the isolated virgin and pregnant rat uterus and cervix, J. Pharmacol. Exp. Ther., 341:587-596, 2012. 

Davis RP, Pattison J, Thompson JM, Tiniakov R, Scrogin KE and Watts, SW: 5-hydroxtryptamine (5-HT) does not reduce total peripheral resistance through direct receptor mediated vascular relaxation of the superior mesenteric artery, BMC Pharmacology, May 6 12(1): 4, 2012.

Tykocki N, Jackson WF and Watts, S. W.: Reverse mode Na+/Ca2+ exchange is an important mediator of venous contraction, Pharmacol Res. 66:544-554, 2012. 

 

2013

Tykocki NR, Thompson JM, Jackson WF and Watts SW: Ryanodine receptors are uncoupled from contraction in rat vena cava.  Cell Calcium, 53:112-119, 2013

Davis RP, Szasz T, Garver H, Burnett R, Tykocki N and Watts, SW: One month serotonin infusion results in a prolonged fall in blood pressure in the male deoxycorticosterone acetate (DOCA) salt rat, ACS Chem Neurosci, 4:141-148, 2013.  

Szasz T, Davis RP, Garver HS, Burnett RJ, Fink GD and Watts SW: Long term inhibition of xanthine oxidase by febuxostat does not decrease blood pressure in deoxycorticosterone acetate (DOCA) salt hypertensive rats, PloS ONE, 8(2):e56046. doi:10.1371/journal.pone.0056046, 2013.  

Watts SW, Dorrance AM, Penfold ME, Rourke JL, Sinal CJ, Seitz B, Sullivan TJ, Charvat TT, Thompson JM, Burnett R and Fink GD: Chemerin connects fat to arterial contraction.  Art. Thromb. Vasc. Biol, 33:1320-1328, 2013. 

 

2014

Seitz, B. M. and Watts, S. W.: Serotonin-induced hypotension is mediated by a decrease in intestinal resistance, Pharmacologica, 5(2): 50-54. 2014.

Tykocki, N., Wu, B., Jackson, W. and Watts, S. W.: Divergent signalling mechanisms for venous versus arterial contraction as revealed by endothelin-1, J Vasc Surgery, 014 Apr 10. pii: S0741-5214(14)00358-9. doi: 10.1016/j.jvs.2014.03.010. [Epub ahead of print] 2014.

Ayala-Lopez, N, Martini M, Jackson W F, Darios E, Burnett R, Mahon B, Fink, G. D. and Watts, S. W.: Perivascular adipose tissue contains functional catecholamines.  Pharmacology Research and Perspectives, Volume 2, Issue 3, June 2014. 

Young, L., W., Thompson, J. M., Hitomi, K. and Watts, S. W.: Present and active: transglutaminases in the virgin rat uterus and cervix, The Open Access Reproductive Sciences Journal, Vol 6, 2014. [DOI: 10.2174/1874255620140708001]

Ferland D, Darios ES, and Watts, S. W.: The persistence of active smooth muscle in the female rat cervix through pregnancy, Am J Obstet Gynecol,  212:244e1-8, 2014. 

Watts, S. W.: Serotonin and the sensory nerves:  Meeting in the cardiovascular system, Vasc Pharmacol, 63:1-3, 2014. 

Ni, W, Watts, S. W., Ng, M, Chen, S, Glenn, D. J. and Gardner, D. G: Elimination of vitamin D receptor in vascular endothelial cells alters vascular function, Hypertension, 64:12901298, 2014. 

Penumatsa K, Abualkhair S, Wei L, Warburton R, Preston I, Hill NS, Watts S.W., Fanburg BL and Toksoz D: Tissue transglutaminase promotes serotonin-induced AKT signaling and mitogenesis in pulmonary vascular smooth muscle cells, Cellular Signalling, 26(12):2818-2825, 2014.

 

2015

Watts, S. W., Darios, E., Seitz, B. M., Burnett, R and Thompson, J. M.: 5-HT is a potent relaxant in rat superior mesenteric arteries? Pharmacology Research and Perspectives, e00103.doi:10.1102/prp2.103, 2015. 

Petersen-Jones, H., Johnson, K., Hitomi, K., Tykocki, N., Thompson, J. and Watts, S. W.: Transglutaminase activity is decreased in large arteries from hypertensive rats compared to normotensive controls, Am J Physiol Heart Circ Physiol, 308:H592-602, 2015.

Watts, S. W., Tykocki, N. and Jesperson, B : Measurement of smooth muscle function in the isolated tissue bath- Applications to pharmacology research, JoVE, Jan 19; (95) doi:10.3791/52324, 2015.  http://www.jove.com/video/52324.

Darios, E.S., Barman, S. M., Orer, H. S., Morrison, S. F., Davis, R. P, Seitz, B. M., Burnett, R. and Watts, S. W.: 5-hydroxytryptamine does not reduce sympathetic nerve activity of neuroeffector function in the splanchnic circulation, Eur. J Pharmacol, 754:140-147, 2015. 

Watts, SW: The two faces of serotonin.  International Innovations.  http://digimag.internationalinnovation.com/launch.aspx?eid=6092cfa6-5a48-4f36-b47c-d73ca34bdbec, 2015. 

Watts, S. W.: Trash talk by fat: chemerin as an ROS Provocateur in the vasculature, Hypertension, 115.05738, 2015.

Ferland D.J. and Watts, S. W.: Chemerin: A comprehensive review elucidating the need for cardiovascular research.  Pharmacol. Res. 99:351-361, 2015. 

Young LW, Darios ES and Watts, SW: An immunohistochemical analysis of SERT in the blood brain barrier of the male rat brain.  Histochem. Cell Biol, 44:321-329, 2015. 

Ayala-Lopez, N., Jackson, W. F., Burnett, R., Wilson, J. N. and Watts, S. W.: Organic cation transporter-3 contributes to norepinephrine uptake in perivascular adipose tissue, Am J Physiol Heart Circ Physiol, 309:H1904-1914, 2015.  w

Cho K, Clementi E, Levi-Schaffer F, Smalley KS, Radice S and Watts, S. W.: Pharmacological research and precision cancer medicine: A call for manuscripts.  Pharmacol Res. 102: 308-309, 2015. 

Cho K, Clementi E, Levi-Schaffer F, Smalley KS, Radice S and Watts SW: Introducing a checklist for manuscript submission to Pharmacological Research.  Pharmacol Res 102:319-321, 2015.

 

2016

Seitz, B. M., Krieger-Burke Teresa, Fink, G. D. and Watts, S. W.: Serial measurements of splanchnic vein diameters in rats using high frequency ultrasound, Front. Pharmacol., 03 May 2016 | http://dx.doi.org/10.3389/fphar.2016.00116

Moore, A., Zabel, B. A., Burnett, R. and Watts, S. W.: Chemerin C9 peptide releseas catecholamines from rat adrenal medulla, Pharmacologia 7:290-295, 2016.

Darios, E. S., Winner, B. M., Charvat, T., Karsinksi, A., Punna, S. and Watts, S.W.: The adipokine chemerin amplifies electrical field stimulated contraction in the isolated superior mesenteric artery,  Am J Physiol Heart Circ Physiol, 311:H498-H507, 2016.

Contreras, G. A., Thelen, K., Ayala-Lopez, N. and Watts, S. W.: The distribution and adipogenic potential of perivascular adipose tissue adipocyte progenitors is dependent on sexual dimorphism and vessel location, Physiol Reports, oct;4(19). Pii: e12993, 2016.

Watts, S. W.: Oh the places you’ll go! My many colored serotonin (apologies to Dr. Seuss), Am J Physiol Heart Circ Physiol, H1225-H1233, 2016.

Ayala-Lopez, N. and Watts, S. W.: New actions of an old friend: adrenergic mechanisms within perivascular adipose tissue, in press, Br. J. Pharmacol, doi: 10.1111/bph.13663, 2016.

Thelen, K. Ayala-Lopez, N. Watts, S. W. and Conteras G: The isolation, expansion and induction of adipocyte progenitors from perivascular adipose tissue, invited methods article, accepted, JoVE, 2016.

Rorabaugh, B., R., Chakravarti, B., Mabe, N. W., Seeley, S. L., Bui, A. D., Yang, J., Watts, S. W., Neubig, R. R. and Fisher, R. A.: Regulator of G protein 6 protects the heart from ischemic injury, in press, J. Pharmacol Exp. Ther. Dec 29, 2016 ePub ahead of print.

 

2017

 

Thelen K, Ayala-Lopez N, Watts SW, Contreras GA: Expansion and adipogenesis induction of adipocyte progenitors from perivacular adipose tissue isolated by magnetic activated cell sorting, J Vis Exp 30:doi: 10.3791/55818, 2017. 

Ferland D, Darios, E. S., Neubig, R. R., Sjogren, B., Truong, N., Torres, R., Dexheimer, T. S., Thompson J. M. and Watts, S. W.: Chemerin-induced arterial contraction is Gi and calcium-dependent, Vasc Pharmacology, 88:30-41, 2017.

Ismail, A., Ayala-Lopez, N., Ahmad, M. and Watts, S. W.: 3T3-L1 cells and perivascular adipocytes are not equivalent in amine transporter expression, FEBS Letters 591:137-144, 2017. 

Ayala-Lopez, N., Thompson, J. M. and Watts, S. W.: Perivascular adipose tissue’s amine oxidase: impact on NE-induced contraction of mesenteric resistance arteries, Front in Physiol, Vasc Physiol, 8:37. Doi: 10.3389/fphys.2017.00037, 2017.

Rorabaugh BR, Chakravarti B, Mabe NW, Seeley SL, Bui AD, Yang J, Watts SW, Neubig RR, Fisher RA.  J Pharmacol Exp Ther. 2017 Mar;360(3):409-416. doi: 10.1124/jpet.116.238345. Epub 2016 Dec 29.

 Seitz BM, Orer H, Krieger-Burke T, Darios ES, Thompson JM, Fink GD, Watts SW. 5-HT causes splanchnic venodilation. Am J Physiol Heart Circ Physiol. 2017 Jun 16:ajpheart.00165.2017. doi: 10.1152/ajpheart.00165.2017. [Epub ahead of print] PMID: 28626072